Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,528.52
(
2.91%
)
US TECH 100
23,078.06
(
3.34%
)
Dow Jones
46,341.51
(
2.49%
)
Brent Oil
103.28
(
-4.87%
)
Bitcoin
67,999.80
(
1.95%
)
News Focus
News Focus
Post# of 257322
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122830
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Whalatane post# 247732

Tuesday, 06/27/2023 11:56:17 AM

Tuesday, June 27, 2023 11:56:17 AM

Post# of 257322
Just to be clear—The LLY post by jbog (#msg-172218315) was about an injected triple-MoA drug called Retatrutide that is in phase-2; the LLY post by me (#msg-172182849) was about an oral GLP-1 called Orforglipron that is in phase-3.

There are so many injected and oral incretin-mimetic and incretin-receptor-agonist compounds in development that one needs a scorecard to keep track of them all.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today